扶正抑癌汤合并化疗治疗晚期肺癌临床观察

 本文报道“中药扶正抑瘤汤”并用化疗（简称综合组）治疗晚期肺癌35例同单纯化疗组（简称单化组）30例作了比较，以观察“扶正抑瘤汤”在治疗晚期肺癌的临床作用。全部病例均有病理学依据，Karnofsky（卡氏）评分在60～70分。治疗方法：两组病人均接受化疗至少两个疗程，化疗方案：小细胞肺癌（SCLC）用EP与CMC交替q3W，非小细胞肺癌（NSCLC）用VMP或EMP，每疗程间隔3～4周。综合组加中药扶正抑瘤汤口服。结果：综合组和单化组的有效率（CR＋PR）分别为54.28％、30％，统计学有显著差异（P＜0.05），综合组主要症状的改善优于单化组，化疗引起的副作用小于单化组。提示扶正抑瘤汤配合化疗可以起到增效减毒作用，提高患者的生活质量和近期疗效。

Clinical Observation of the Combination of the Chemotherapy and the Support healthy Energy Decoction in the Management of Advanced Lung Cancers

Therapeutic effect of the support healthy energy decoction plus chemotherapy(group A) and chemotherapy only (group B)in the treatment of advanced lung cancerswas compared. Methods: Comparsion of 65 advancde lung cancers was carried out,group A-35 cases and group B-30 cases. The clinical and pathological results werecompared by the X2 test. Results: The group A gave an overall response rate 54.28%,and the group B 30% (P0.05). Meaniwhile, the group A had a better improvement ofthe clinical symptoms and less side toxicities. Conclusion: In advanced lung cancer casesas treated with combination of chemotherapy and the support healthy energy decoction,clinical results were more satisfied than those of group B.